RE:RE:RE:RE:RE:RE:RE:RE:90 daysThat is very helpful Noteable. If pela works well with even a few of them, it is a blockbuster aquisition for Roche.
Tecentriq already accounts for a major share of Roche pharma revenues. Combining with pela would effectively extend their patents also.